Target intelligence / Profile preview

Protein yippee-like 5 (YPEL5)

Target
YPEL5
Molecular classification
Other, Component of CTLH E3 ubiquitin-protein ligase complex, Putative zinc finger protein
01

Overview

Protein yippee-like 5 (YPEL5) is a highly conserved eukaryotic protein and the fifth member of the YPEL family, predicted to contain a zinc finger motif. YPEL5 localizes to the nucleus and centrosome in interphase, then redistributes to spindle poles and spindle midzone throughout mitosis and cytokinesis. It is a key mediator of cell cycle progression, proliferation, and apoptosis, functioning as a component of the CTLH E3 ubiquitin-protein ligase complex to promote degradation of transcription factors such as HBP1. YPEL5 interacts with RanBPM and RanBP10, and in mammals, it acts as a negative regulator of interferon-beta signaling by binding TBK1/IKBKE kinases. Knockdown or loss of YPEL5 disrupts cell division and embryonic development, causing hepatomegaly and lethality in knockout zebrafish, and impairs immune response. In cancer, especially colorectal and hematological malignancies, aberrant YPEL5 expression drives cell proliferation and is subject to epigenetic suppression via the m6A methyltransferase pathway. Overall, YPEL5 is primarily classified as a cell cycle and ubiquitin pathway regulator, with roles in proliferation, apoptosis, immune signaling, and tumor suppression.

Other names
Yippee like 5YPEL5CGI-127Protein yippee-like 5Ypel5yippee protein homologYippee-like 5 (Drosophila)2310076K21Rik
02

Biological functions

Cell cycle progression and regulationCell proliferation and divisionUbiquitin-mediated proteasomal degradation (via ligase complex)Negative regulation of interferon-beta production and immune signalingApoptosis (pro-apoptotic function shown in yeast models)Tumor suppression (especially in colorectal cancer models)
03

Disease associations

Cancer/tumorigenesis (tumor suppressor in colorectal cancer, involved in other cancers through cell cycle)Immune/Inflammation (regulation of innate immune response and interferon-beta signaling)Chromosome 22q11.2 deletion syndrome, distal (listed association)Other (general embryonic development defects, as shown in knockout animal models)

Beyond the preview

Go deeper on Protein yippee-like 5 (YPEL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein yippee-like 5 (YPEL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call